Boston Partners’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-437,043
Closed -$38.5M 811
2017
Q3
$38.5M Sell
437,043
-211,740
-33% -$18.6M 0.05% 258
2017
Q2
$56.4M Buy
648,783
+15,370
+2% +$1.15M 0.07% 228
2017
Q1
$40M Sell
633,413
-10,195
-2% -$674K 0.05% 252
2016
Q4
$42.3M Sell
643,608
-409
-0.1% -$25.6K 0.06% 241
2016
Q3
$44.7M Buy
644,017
+8,105
+1% +$547K 0.06% 230
2016
Q2
$40M Buy
635,912
+302,991
+91% +$18.8M 0.06% 229
2016
Q1
$20.9M Buy
332,921
+5,622
+2% +$347K 0.03% 291
2015
Q4
$22.3M Buy
327,299
+17,166
+6% +$1.12M 0.03% 287
2015
Q3
$19.2M Buy
310,133
+5,648
+2% +$380K 0.03% 292
2015
Q2
$19.6M Buy
304,485
+32,277
+12% +$2.17M 0.03% 310
2015
Q1
$18.8M Sell
272,208
-12,621
-4% -$804K 0.03% 307
2014
Q4
$15.8M Sell
284,829
-9,976
-3% -$575K 0.02% 337
2014
Q3
$18.6M Buy
294,805
+10,047
+4% +$573K 0.03% 296
2014
Q2
$15M Sell
284,758
-635
-0.2% -$31.8K 0.03% 327
2014
Q1
$15.4M Sell
285,393
-579
-0.2% -$29.7K 0.03% 330
2013
Q4
$12.9M Sell
285,972
-5,861
-2% -$268K 0.03% 352
2013
Q3
$14.7M Sell
291,833
-4,251
-1% -$208K 0.04% 301
2013
Q2
$13.6M Buy
+296,084
New +$13M 0.04% 294

Other funds holding PRXL

Boston Partners's PRXL Position: Q4 2017 in Review

Boston Partners sold out of Parexel International Corp (PRXL) in Q4 2017, closing a stake of 437,043 shares — an estimated $38.5M sold.

Boston Partners first reported a position in PRXL in Q2 2013 and held it in 18 quarters. The position peaked at $56.4M in Q2 2017. 1 fund tracked by Wall St. Rank holds PRXL as of Q4 2017.

  • Boston Partners reported no remaining Parexel International Corp position as of Q4 2017 after selling out during the quarter.
  • Boston Partners sold 437,043 Parexel International Corp shares in Q4 2017, an estimated $38.5M.
  • Boston Partners first reported a position in Parexel International Corp in Q2 2013 and held it in 18 quarters.
  • Boston Partners's Parexel International Corp position peaked at $56.4M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Parexel International Corp as of Q4 2017.

Based on Boston Partners's 13F filing for Q4 2017, filed 1 Feb 2018.